Skip to content

Effectiveness of meaning-centered group psychotherapy in young-middle aged patients with cancer: study protocol for a randomized controlled trial

Effectiveness of meaning-centered group psychotherapy in young-middle aged patients with cancer: study protocol for a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060672
Enrollment
Unknown
Registered
2022-06-07
Start date
2022-06-07
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumor

Interventions

Observation group:None
control group:usual care
Intervention group:meaning-centered group psychotherapy

Sponsors

Shanghai Proton Heavy Ion Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: I. ? Age between 18-60 years old; ? Patients who are informed about the diagnosis; ? Those who have the ability to listen, speak, read and write, and can understand and answer questions correctly; ? Voluntarily participate in this study and sign the informed consent form. ??Participate in the first phase of the study and the information is valid. ? Informed consent to participate in this study voluntarily ?? Age between 20-49 years old; ? Hospitalized patients with solid tumors; ? Patients who are informed of the diagnosis and can understand Mandarin; ? Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: I. ? Patients in the acute stage of the disease, or patients with a combination of severe hepatic and renal function, cardiopulmonary function impairment; ? Those with severe mental disorders or severe cognitive function deficiencies; ? Those who have poor physical tolerance and are unable to complete the questionnaire. ?? Patients who refuse to participate in the interview. ?? Patients in the acute stage of the disease, or patients with severe liver and kidney function, heart and lung function damage; ? Patients with severe mental disorders or severe cognitive function defects; ? Patients with the help of other drugs or participating in other similar psychological interventions.

Design outcomes

Primary

MeasureTime frame
Meaning of life;

Secondary

MeasureTime frame
Psychological distress;Post-traumatic growth;

Countries

China

Contacts

Public ContactWan Hongwei

Shanghai Proton Heavy Ion Hospital

hong_whw@aliyun.com+86 151 5382 0256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026